REG - Marwyn Value Inv Ltd Marwyn Value Inv Ltd Marwyn Value - MVR2 Marwyn Value - MVIR - Notice of Annual General Meeting

Marwyn Value InvestorsAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nRSC7529Fa&default-theme=true

RNS Number : 7529F  Marwyn Value Investors Limited  03 November 2025

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN
WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

3 November 2025

 

Marwyn Value Investors Limited

(The "Company")

NOTICE OF ANNUAL GENERAL MEETING

The Company announces that the Notice of the Annual General Meeting of the
Company is being posted to shareholders today. The Annual General Meeting is
to be held at the offices of Travers Smith LLP, 10 Snow Hill, London, EC1A 2AL
at 10:00 a.m. on 10 December 2025.

The Notice will also be available on the Company's website
at www.marwynvalue.com (http://www.marwynvalue.com/)
/company-information/documents.

Company enquiries:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

 

Company Secretary

Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Panmure Liberum Limited

Chris Clarke

Telephone: 0203 100 2200

 

 
Shares in the Company are not designed or intended for retail investors.
Marwyn Investment Management LLP, the Manager, does not promote shares in the
Company to retail investors and they should not be offered to retail
investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAPKBBBDBDDNDK



            Copyright 2019 Regulatory News Service, all rights reserved